Skip to main content
. 2021 Apr 12;49(4):0300060520984933. doi: 10.1177/0300060520984933

Table 4.

Previous studies.

Authors Patients, n Primary tumor Endovascular technique Adverse events Follow-up outcome
Huang et al.2 1 Cervical squamous cell carcinoma SG None None
Salaskar et al.6 1 Rectal adenocarcinoma Coil and Gelfoam embolization None Asymptomatic for 3 years
Chen et al.15 6 Cervical cancer Coil/PVA/NBCA embolization in all patients;SG in Patients 5 and 6 Mild transient pelvic pain Patient 1: 3.5 months/disease progressionPatient 2: 10.5 months/disease progressionPatient 3: 34 months/alivePatient 4: 5 months/disease progressionPatient 5: 3 months/bleedingPatient 6: 2.5 months/disease progression
Watarida et al.18 1 Adenocarcinoma of the uterine cervix Coil and Gelfoam embolization combined with FFB None None

SG, stent graft; PVA, polyvinyl alcohol; NBCA, N-butyl-2-cyanoacrylate; FFB, femorofemoral bypass